[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336818-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336818-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","m6a-modification-of-rna-in-cervical-cancer-role-and-clinical-perspectives","m6A modification of RNA in cervical cancer - role and clinical perspectives","","N6-methyladenosine (m6A) is the predominant RNA modification in higher organisms and regulates RNA metabolism, shaping gene expression, cell proliferation, invasion and metastasis, cell-cycle control, programmed cell death, tumor microenvironment interactions, energy metabolism, and immune regulation. Mechanistic advances in RNA methylation increasingly clarify m6A’s role in the pathophysiology of reproductive-system tumors, especially cervical cancer. This review summarizes m6A biological functions and mechanisms in cervical cancer onset and progression, and evaluates its potential for precision diagnosis and treatment, providing a theoretical basis for innovative therapeutic strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/m6a-modification-of-rna-in-cervical-cancer-role-and-clinical-perspectives/336818/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/m6a-modification-of-rna-in-cervical-cancer-role-and-clinical-perspectives/336818.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is m6A modification and why is it important in cervical cancer?","Question",{"text":63,"@type":64},"m6A is the predominant RNA modification in higher organisms and regulates RNA metabolism. The review links m6A to key biological processes and highlights its pivotal role in cervical cancer pathophysiology.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which RNA processes can m6A modification influence?",{"text":68,"@type":64},"The review states that m6A affects gene expression-related steps including splicing, nuclear export, localization, translation, and degradation.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the major components of the m6A methyltransferase (writer) complex?",{"text":72,"@type":64},"The article describes methyltransferase complexes including METTL3, METTL14, and WTAP, along with additional factors such as ZC3H13, RBM15/RBM15B, METTL16, and KIAA1429 that support localization and site-specific methylation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336818,1790167919,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","REVIEW  \nm6A modification of RNA in cervical cancer: role and clinical perspectives  \nYajuan Gao, Qi Guo, and Liming Yu   \nDepartment of Gynecology and Obstetrics, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, China  \nABSTRACT  \nN6-methyladenosine (m6A) is widely recognized as the predominant form of RNA modification in higher organisms, with the capability to finely regulate RNA metabolism, thereby influencing a series of crucial physiological and pathological processes. These processes include regulation of gene expression, cell proliferation, invasion and metastasis, cell cycle control, programmed cell death, interactions within the tumour microenvironment, energy metabolism, and immune regulation. With advancing research into the mechanisms of RNA methylation, the pivotal role of m6A modification in the pathophysiology of reproductive system tumours, particularly cervical cancer, has been progressively unveiled. This discovery has opened new research avenues and presented significant potential for the diagnosis, prognostic evaluation, and treatment of diseases. This review delves deeply into the biological functions of m6A modification and its mechanisms of action in the onset and progression of cervical cancer. Furthermore, it explores the prospects of m6A modification in the precision diagnosis and treatment of cervical cancer, aiming to provide new perspectives and a theoretical basis for innovative and advanced treatment strategies for cervical cancer.  \nARTICLE HISTORY  \nRevised 30 August 2024 Accepted  \n17 September 2024  \nKEYWORDS  \nN6-methyladenosine; m6A; RNA modification; cervical cancer; clinical value  \n1. Introduction  \nCervical cancer (CC) is identified by the International Agency for Research on Cancer (IARC), a division of the World Health Organization, as the fourth leading cause of death among women globally. In 2022, it accounted for approximately 661,021 new cases and 348,189 deaths worldwide [ 1] . The primary treatment methods include surgical interventions, radiotherapy, chemotherapy, and more recently, emerging targeted therapies and immunotherapies. Despite the diversity of treatment options, the prognosis for advanced cervical cancer remains poor, with recurrent issues of drug resistance and relapse. Moreover, significant inter-individual variability in treatment responses highlights a critical gap ineffective personalized therapeutic strategies.  \nThe m6A modification, a pervasive epigenetic modification across various RNA molecules, plays a crucial role in RNA metabolism. It influences RNA splicing, nuclear export, localization, translation, and degradation, serving as a significant modality for regulating gene expression [2] . The m6A modification is enriched in the 3’ untranslated region (3’UTR) adjacent to the RNA termination codon, with a predominant RRACH sequence motif (where R stands for G or A, and H denotes A, C, or U) [3,4] . Research demonstrates the multifaceted roles of m6A modifications, occurring not solely within mRNA but also within distinctive motifs of noncoding RNAs (ncRNAs)– circular RNA (circRNA), long noncoding  \nRNA (lncRNA), micro RNA (miRNA) and et al. [5] . Analogous to DNA and histone methylation, the m6A modification is characterized by its reversible and dynamic nature, modulated predominantly by the enzymatic activities of ‘writers’, ‘erasers’, and ‘readers [6]’. The roles and categorization of m6A enzymes in RNA metabolism are detailed in Table 1.  \nMethyltransferase complexes (MTC), known as ‘writers’, mediate RNA methylation. This complex primarily includes methyltransferase-like 3 (METTL3) [7], methyltransferase-like 14 (METTL14) [8], and Wilms tumour 1-associated protein (WTAP) [ 10]. METTL3, serving as the primary catalytic component, and METTL14, which acts more as a regulatory and RNAbinding scaffold, work synergistically to enhance methylation efficiency when co-localized within nuclear speckles [26]. WT","cbCait3KHrqcvgIY","https://ap.wps.com/l/cbCait3KHrqcvgIY","pdf",2178830,13,"English","# Introduction\n## m6A modification in RNA metabolism\n## m6A “writers”, “erasers”, and “readers”\n# Methyltransferase complexes (writers)\n## Core components and functions","[{\"question\":\"What is m6A modification and why is it important in cervical cancer?\",\"answer\":\"m6A is the predominant RNA modification in higher organisms and regulates RNA metabolism. The review links m6A to key biological processes and highlights its pivotal role in cervical cancer pathophysiology.\"},{\"question\":\"Which RNA processes can m6A modification influence?\",\"answer\":\"The review states that m6A affects gene expression-related steps including splicing, nuclear export, localization, translation, and degradation.\"},{\"question\":\"What are the major components of the m6A methyltransferase (writer) complex?\",\"answer\":\"The article describes methyltransferase complexes including METTL3, METTL14, and WTAP, along with additional factors such as ZC3H13, RBM15/RBM15B, METTL16, and KIAA1429 that support localization and site-specific methylation.\"}]","m6A modification of RNA in cervical cancer - role and clinical perspectives | PDF",1790016731,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a564131bd467f39f237cd4691ba1fe5.webp",983,1280,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d5827e760eda4cb1581a30c0d5029cf.webp",982,1278,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/648d828a2937fb1d7efd7e39dba851ad.webp",981,1277,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4dfa74af46d0ad3c0808b883563218c4.webp",980,1276]